27 Jun 2010
GENERIC NAME: ACETYLCYSTEINE - INHALATION/ORAL (a-set-ill-SIST-een)
BRAND NAME(S): Mucomyst
This medication, when inhaled by mouth, works in the lung to thin mucous, making breathing easier. It is used to treat thick mucous secretions in chronic emphysema, bronchitis, pneumonia, cystic fibrosis and other related conditions. This medication is also swallowed by mouth as an antidote to acetaminophen overdose in order to prevent life-threatening liver damage.
OTHER USES: Acetylcysteine has also been swallowed by mouth to prevent kidney failure due to X-ray contrast products.
HOW TO USE: When used to thin mucus, this medication is inhaled into the lungs using special breathing (nebulizer) equipment. A health care professional will demonstrate the proper way to use the equipment. Make sure you understand and ask any questions you may have. Use the solution as directed. Do not increase your dose or take this more frequently than directed. When swallowed by mouth for acetaminophen overdose or to prevent kidney problems, take exactly as directed. For acetaminophen overdose, this medication is generally used every 4 hours.
Still contact your doctor
- Acetylcysteine Information for Consumers
- Acetylcysteine Information for Healthcare Professionals (includes dosage details)
- Side Effects of Acetylcysteine (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
I have been researching Pulmonary Fibrosis and I have found a number of treatments available. My question to you is what treatment is the best one to ...
1 answer • 29 Jul 2010
... been told that the drug pirespa has shown positve signs. This drug, as I understand it has only been approved in Japan. I have a prescription ...
1 answer • 3 Oct 2010
He has just been diagnosed.
2 answers • 21 Feb 2011
... drugs)? The hypothesis is that surfactant (which keeps the alveoli in your lungs inflated) needs cholesterol, so if it is inhibited the alveoli ...
1 answer • 6 Mar 2012
... study for Esbriet?
1 answer • 11 Jun 2014